Notification of Results

RNS Number : 6128J
Fevertree Drinks PLC
14 April 2020
 

14th April 2020

Fevertree Drinks plc

 ("Fever-Tree" or the "Group")

 

Notification of Results

Fever-Tree, the world's leading supplier of premium carbonated mixers, will publish its preliminary results for the 52 weeks ended 31 December 2019 on Wednesday 22 April 2020.

The results are being announced later than originally planned following the request from the Financial Conduct Authority (FCA) on 21 March 2020 for public companies to observe at least a two week moratorium on the publication of preliminary results.

 

For further information:

Fevertree Drinks plc                                                                      

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Ann Hyams, Director of Investor Relations                                     +44 (0)7435 828 138 

 

Numis Securities - Nominated Adviser and Joint Broker  +44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein

 

Investec Bank plc - Joint Broker                                               +44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson 

 

Brunswick Group                                                                         +44 (0) 20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud

 

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 75 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On-Trade") as well as selected retail outlets ("Off-Trade").

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORSFUFDLESSEFL
UK 100

Latest directors dealings